Michaela Praus

Subcutaneous immunoglobulin for maintenance treatment in chronic inflammatory demyelinating polyneuropathy (PATH): a randomised, double-blind, placebo-controlled, phase 3 trial

Ivo N. van Schaik, Vera Bril, Nan van Geloven et al. · The Lancet Neurology · 2017 · 269 citations · Full text

Life Sciences, Neurology, Pharmacotherapy +11

Fast rise of broadly cross-reactive antibodies after boosting long-lived human memory B cells primed by an MF59 adjuvanted prepandemic vaccine

Grazia Galli, Kathy Hancock, Katja Höschler et al. · Proceedings of the National Academy of Sciences · 2009 · 261 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Dose ranging of adjuvant and antigen in a cell culture H5N1 influenza vaccine: Safety and immunogenicity of a phase 1/2 clinical trial

Wendy A. Keitel, Nicola Groth, Maria Lattanzi et al. · Vaccine · 2009 · 72 citations

Veterinary Medicine, Immunology, Infectious Diseases +17

Phase I Comparability of Recombinant Human Albumin and Human Serum Albumin

Dietrich Bosse, Michaela Praus, Lars Nyman et al. · The Journal of Clinical Pharmacology · 2004 · 61 citations

Pharmacy, Pharmacokinetics, Pharmacology +10

Long-term safety and efficacy of subcutaneous immunoglobulin IgPro20 in CIDP

Ivo N. van Schaik, Orell Mielke, Vera Bril et al. · Neurology Neuroimmunology & Neuroinflammation · 2019 · 51 citations · Full text

Medicine, Neurology, Pharmacotherapy +14